Kevin Chinn, vice president and head of the cell & gene therapy service line at Cencora, outlines why early planning, ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Nate Chenenko, principal with Ducker Carlisle, explains the meaning behind Scope 3 emissions, including why they ...

In the fourth part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, explains the market dynamics or stakeholder misalignments that need to be resolved in order for the next ...

Agreement allows educational institutions to access cold chain packaging solutions without the typical request for proposal ...

In the third part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, outlines alternative reimbursement ...

In the fifth part of this roundtable discussion, a panel of KOLs explore how the chain of custody and chain of ownership are ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life ...

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

Meanwhile, President Trump continues to push reciprocal levies and reshoring efforts, while pharma prepares for escalating ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life ...

In the second part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, explains how dual-action metabolic ...

As new pricing and trade policies take shape, 60% of life sciences and healthcare executives anticipate business disruption, ...